Announcement PDF Avecho Biotechnology Limited | ASX: AVE | ACN: 056 482 403 | ABN: 32 056 482 403 Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168 avecho.com.au ASX Announcement 12 August 2026 SMALL HOLDING SHARE SALE FACILITY COMPLETION Melbourne, Australia, 12 August 2026: Avecho Biotechnology Limited (ASX: AVE) (Avecho or the Company) is pleased to advise that it has successfully completed the sale of Small Holdings, as previously announced on 27 May 2026. The Facility was offered to shareholders holding Small Holdings to enable them to sell their shares without incurring brokerage or handling costs, which might otherwise have rendered the sale of such small holdings uneconomic or difficult. As at the record date on Monday, 25 May 2026 (Record Date), there were 2,934 Eligible Holders who held a total of 33,843,652 shares with a value of less than $500. Under the Facility, 15,744,635 shares were sold on behalf of 2,113 shareholders, representing approximately 37% of the Company's total shareholders as at the Record Date and approximately 0.41% of issued capital. As a result, the number of shareholders on the register has reduced from 5,751 to 3,761, reducing the Company's ongoing share registry and administrative costs. The Company engaged CPS Capital Group Pty Ltd to conduct the sale of the shares on behalf of participating shareholders. The Facility was conducted in accordance with clause 14 of the Company's Constitution and ASX Listing Rule 15.13. Shareholders whose shares were sold under the Facility will have their proceeds remitted to them and will be sent documentation advising them of the number of shares sold and the amount of proceeds remitted. If a shareholder's bank details require updating, please contact Computershare Investor Services Pty Limited on 1300 850 505 (within Australia) or +61 3 9415 4000 (outside Australia), or update your details at www.investorcentre.com/au. For enquiries, please contact Dr Paul Gavin Chief Executive Officer Avecho Biotechnology Limited +61 3 9002 5000 This announcement has been authorised by the Board of Directors of Avecho Biotechnology Limited.